benign tumor originating from glandular tissue fibroadenoma
Conditions
Interventions
None listed
Sponsors
Universitair Medisch Centrum Utrecht
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria for volunteers: Women Age >= 18 years Weight = 18 years Weight
Exclusion criteria
Exclusion criteria: Exclusion criteria for volunteers and patients with fibroadenomas: Contra-indications to MRI scanning according to the guidelines of the hospital Pregnant or lactating women Volunteers and patients who don*t want to be informed about unexpected findings.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The main study endpoints are: - image quality --> assessed by a score based on delineation of anatomical structures, contrasts, SNR and artefacts of both MRI scans. - lesion descriptors of the BI-RADS lexicon in patients with a fibroadenoma --> described by shape and margin of the lesion and other findings on the MRI scans (e.g. edema, lymphadenopathy, skin thickening). | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary study endpoints - geometric deformation in breasts with different sizes --> assessed by overlaying the two MRI scans and assess whether there is deformation and assess the variety of deformation in breasts with different sizes. - size of fibroadenoma --> assessed by scoring the maximum diameter of the fibroadenoma in 3 orthogonal planes (MaxTrans, MaxSag, MaxCor) on both MRI scans. - relative position of the fibroadenoma --> assessed by measuring the shortest distance from the fibroadenoma to the musculus pectoralis, the chest wall and the skin in 3 orthogonal planes (MaxTrans, MaxSag, MaxCor) on both MRI scans. | — |
Countries
Netherlands
Outcome results
None listed